1. Tufts Center for the Study of Drug Development: Outlook 2002; http://

2. Lesko, L.J.; Rowland, M.; Peck, C.C.; Blaschke, T.F. Optimizing the Science of Drug Development—Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans. J Clin Pharmacol 2000, 40 803-814.

3. Miller, R.R. Hospital Admissions Due to Adverse Drug Reactions—A Report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974, 134, 219-223.

4. Mitchell, A.A.; Goldman, P.; Shapiro, S.; Slone, D. Drug Utilization and Reported Adverse Reactions in Hospitalized Children. Am J Epidemiol 1979, 110, 196204.

5. Lazarou, J.; Pomeranz, B.H.; Corey, P.N. Incidence of Adverse Drug Reactions in Hospitalized Patients—A Meta-Analysis of Prospective Studies. JAMA 1998, 279, 1200-1205.

6. Ernst, F.R.; Grizzle, A.J. Drug-Related Morbidity and Mortality: Updating the Cost-of-illness Model. J Am Pharm Assoc 2001, 41, 192-199.

7. Kohn, L.T.; Corrigan, J.M.; Donaldson, M.S., Eds. To Err is Human: Building a Safer Health System, Institute of Medicine, The National Academies Press, 2000.

8. Cross, J.; Lee, H.; Westelinck, A.; Nelson, J.; Grudzinskas, C.; Peck, C. Postmarketing Drug Dosage Changes of 499 FDA-Approved New Molecular Entities, 1980-1999. Pharmacoepidemiology and Drug Safety 2002, 11, 439446.

9. Cohen, J.S. Overdose: The Case Against the Drug Companies—Prescription Drugs, Side Effect, and Your Health, Penguin Putnam, Inc., 2001.

10. Lesko, I.J.; Williams, R.L. The Question-Based Review: A Conceptual Framework for Good Review Practices. Applied Clinical Practice 1999, 8, 56-62.

11. Dako, A.S. Cytomation, Inc.

12. Lesko, L.J.; Woodcock, J. Pharmacogenomic-Guided Drug Development— Regulatory Perspective. The Pharmacogenomics Journal 2002, 2, 20-24.

13. Philips, K.A.; Veenstra, D.L.; Oren, E.; Lee, J.K.; Sadee, W. Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions—A Systematic Review. JAMA 2001, 2867, 2270-2279.

14. Derendorf, H.; Lesko, L.J.; Chaikin, P.; Colburn, W.; Lee, P.; Miller, R et al. Pharmacokinetic/Pharmacodynamic Modeling in Drug Research and Development. J Clin Pharmacol 2000, 40, 1399-1418.

15. Gieschke, R.; Steimer, J.L. Pharmacometrics—Modeling and Simulation Tools to Improve Decision-Making in Clinical Drug Development. Eur J Drug Metab Pharmacokinet 2000, 25, 49-58.

Was this article helpful?

0 0

Post a comment